Boehringer Can Keep Many Docs On Barr Deal Away From FTC
By Melissa Lipman ( September 27, 2012, 8:41 PM EDT) -- A Washington federal judge ruled Thursday that many of the documents the Federal Trade Commission had sought from Boehringer Ingelheim Pharmaceuticals Inc. about its patent settlements with Barr Pharmaceuticals Inc. were privileged but ordered the drugmaker to quickly turn over the rest....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.